Atlas Trials

SWISS BIOPHARMA MED GmbH

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch SWISS BIOPHARMA MED GmbH

RecordFirmDate
Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma (NCT04895566)SWISS BIOPHARMA MED GmbH2021-05-24

Track SWISS BIOPHARMA MED GmbH automatically

Every clearance here is in the API, with alerts when new ones post.